OKYO Pharma (OKYO) has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 24,551 of the Company’s ordinary shares on NASDAQ, bringing his total holding to 10,516,297 shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
- OKYO Pharma Reports Positive Phase 2 Results for Urcosimod in Neuropathic Corneal Pain
- Okyo Pharma’s urcosimod shows favorable corneal nerve outcomes in Phase 2 trial
- Okyo Pharma initiated with a Buy at B. Riley
- OKYO Pharma’s Chairman Increases Stake Amidst Phase 2 Trial Completion
- Okyo Pharma chairman acquires 27,051 company shares